For the efficient delivery of peptide and protein drugs by non-invasive rou
tes various strategies have been pursued to overcome enzymatic and mucosal
barriers to gain sufficient bioavailability. Among such delivery systems mu
ltifunctional polymers have received considerable attention, which is refle
cted by numerous publications and patents. They are able to provide a contr
olled release for therapeutic peptides and proteins being embedded in the p
olymeric network either based on a simple diffusion process or on the biode
gradation of the carrier matrix. Additionally, polymers such as polyacrylat
es display an inhibitory effect towards various proteases located on the ab
sorption membrane. In combination with enzyme inhibitors, this protective e
ffect towards enzymatic attack may further be improved. Moreover, polyacryl
ates and chitosan display a permeation enhancing effect, in particular for
the paracellular uptake of peptide drugs from mucosal tissues. If these pol
ymers also exhibit mucoadhesive properties, the concentration gradient of t
he drug on the mucosa can be increased and in the case of oral delivery the
presystemic enzymatic degradation of the (poly)peptide drug in the intesti
ne between the delivery system and the absorption membrane can be reduced.
Delivery systems utilising multifunctional polymers include formulations su
ch as nano- and microspheres, pellets and matrix-tablets.